- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about IMVT
Recent news which mentions IMVT
What's Going On Pfizer's Subsidiary Biohaven Stock?
September 27, 2023
From Benzinga
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 27, 2023
From Benzinga
Why Immunovant Stock Is Bolting Higher Today
September 27, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
From Benzinga
MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big Stocks Moving Higher On Wednesday
September 27, 2023
From Benzinga
Why Shares of Immunovant Are Soaring on Tuesday
September 26, 2023
From Motley Fool
Nasdaq Down 1.5%; Immunovant Shares Spike Higher
September 26, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 26, 2023
From Benzinga
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
From Benzinga
Crude Oil Moves Higher; Cintas Earnings Top Estimates
September 26, 2023
From Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
From Benzinga
Why Is Autoimmune Disease-Focused Immunovant Stock Trading Higher Today?
September 26, 2023
From Benzinga
These 2 Biotech Stocks Are Bucking a Down Market Tuesday
September 26, 2023
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 26, 2023
From Benzinga
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
September 18, 2023
From Benzinga
If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
August 25, 2023
From Benzinga
Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development
July 18, 2023
From Benzinga
From InvestorPlace
Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 17, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.